Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models
Compose a Response to This Article
Other responses
No responses have been published for this article.